폐포단백증 환자에서 전폐세척술을 위한 Propofol-Remifentanil 마취 관리
Anesthetic Management of Whole-Lung Lavage Using Propofol-Remifentanil in a Patient with Pulmonary Alveolar Proteinosis
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Pulmonary alveolar proteinosis (PAP) is characterized by the progressive accumulation of phospholipids and proteins within the alveolar sacs without producing an inflammatory response. Whole-lung lavage (WLL) is performed as the standard therapy for this disease because it serves to wash out the proteinaceous material from the alveoli. In this case, we performed sequential WLL using propofol-remifentanil, which is not related to hypoxic pulmonary vasoconstriction during one-lung ventilation. The patient's symptoms and radiologic findings showed improvement without the occurrence of any specific complications. Therefore, we report a case of anesthetic management of WLL performed repeatedly for a patient with recurrent PAP.
Abstract
Pulmonary alveolar proteinosis (PAP) is characterized by the progressive accumulation of phospholipids and proteins within the alveolar sacs without producing an inflammatory response. Whole-lung lavage (WLL) is performed as the standard therapy for this disease because it serves to wash out the proteinaceous material from the alveoli. In this case, we performed sequential WLL using propofol-remifentanil, which is not related to hypoxic pulmonary vasoconstriction during one-lung ventilation. The patient's symptoms and radiologic findings showed improvement without the occurrence of any specific complications. Therefore, we report a case of anesthetic management of WLL performed repeatedly for a patient with recurrent PAP.
참고문헌 (16)
- Rosen SH, "Pulmonary alveolar proteinosis", N Engl J Med, 258, pp.1123~1142 (1958)
- Ramirez J, "Pulmonary alveolar proteinosis: a new technique and rationale for treatment", Arch Intern Med, 112, pp.419~431 (1963)
- Michaud G, "Whole-lung lavage for pulmonary alveolar proteinosis", Chest, 136, pp.1678~1681 (2009)
- Pruszkowski O, "Effects of propofol vs sevoflurane on arterial oxygenation during one-lung ventilation", Br J Anaesth, 98, pp.539~544 (2007)
- Kellow NH, "Comparison of the effects of propofol and isoflurane anaesthesia on right ventricular function and shunt fraction during thoracic surgery", Br J Anaesth, 75, pp.578~582 (1995)
- Abe K, "The effects of propofol, isoflurane, and sevoflurane on oxygenation and shunt fraction during one-lung ventilation", Anesth Analg, 87, pp.1164~1169 (1998)
- Yoon JR, "Anesthetic management for whole-Lung lavage in a patient with pulmonary alveolar proteinosis", Korean J Anesthesiol, 27, pp.197~206 (1994)
- Oh YS, "Bilateral sequential bronchopulmonary lavage in one stage for recurred pulmonary alveolar proteinosis", Korean J Anesthesiol, 35, pp.172~176 (1998)
- Jayaraman S, "Whole lung lavage for pulmonary alveolar proteinosis", Lung India, 27, pp.33~36 (2010)
- Beccaria M, "Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis", Eur Respir J, 23, pp.526~531 (2004)
- Webb ST, "Anaesthesia for serial whole-lung lavage in a patient with severe pulmonary alveolar proteinosis: a case report", J Med Case Rep, 2, pp.360~ (2008)
- Cohen E, "Bronchopulmonary lavage: effects on oxygenation and hemodynamics", J Cardiothorac Anesth, 4, pp.609~615 (1990)
- Miller RD, "Miller's anesthesia. 7th ed", pp.1844~ (2010), Churchill Livingstone
- Schwarzkopf K, "Lung perfusion, shunt fraction, and oxygenation during one-lung ventilation in pigs: the effects of desflurane, isoflurane, and propofol", J Cardiothorac Vasc Anesth, 17, pp.73~75 (2003)
- Anand K, "Hepatocellular injury following the administration of propofol", Anesthesiology, 95, pp.1523~1524 (2001)
- Liolios A, "Propofol infusion syndrome associated with short-term large-dose infusion during surgical anesthesia in an adult", Anesth Analg, 100, pp.1804~1806 (2005)